Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Gains from Investment Securities: 2014-2023

Historic Gains from Investment Securities for Tvardi Therapeutics (TVRD) over the last 10 years, with Dec 2023 value amounting to $476,000.

  • Tvardi Therapeutics' Gains from Investment Securities rose 1868.42% to $2.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $476,000 for FY2023, which is 303.39% up from last year.
  • Tvardi Therapeutics' Gains from Investment Securities amounted to $476,000 in FY2023, which was up 303.39% from $118,000 recorded in FY2022.
  • Tvardi Therapeutics' 5-year Gains from Investment Securities high stood at $5.7 million for FY2019, and its period low was $118,000 during FY2022.
  • Its 3-year average for Gains from Investment Securities is $519,667, with a median of $476,000 in 2023.
  • In the last 5 years, Tvardi Therapeutics' Gains from Investment Securities crashed by 97.35% in 2020 and then soared by 534.87% in 2021.
  • Yearly analysis of 5 years shows Tvardi Therapeutics' Gains from Investment Securities stood at $5.7 million in 2019, then plummeted by 97.35% to $152,000 in 2020, then spiked by 534.87% to $965,000 in 2021, then crashed by 87.77% to $118,000 in 2022, then spiked by 303.39% to $476,000 in 2023.